The Latest Breaking News from FDA

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.

Tesla has introduced a major enhancement to its humanoid robot, Optimus, featuring new hands.

Amid ongoing uncertainties surrounding the economy and global power dynamics, market volatility continues to dominate. In such times, investing in fundamentally sound blue-chip stocks, Johnson & Johnson (JNJ), American Express (AXP), and AT&T (T), could offer investors a stable foundation, serving as a buffer against market fluctuations and uncertainty. Read…

President-elect Trump's nominees for federal health agencies aim to reshape health oversight in alignment with Robert F. Kennedy Jr.'s health agenda.

"The FDA issued three alerts throughout 2024, warning consumers about lead in certain brands of cinnamon products"

Donald Trump's health team picks includes outspoken critics of the medical establishment and COVID-19 health measures

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

Spices bring up feelings of comfort, cultural belonging and holidays. They can make our homes smell amazing and our food taste delicious. They can satisfy our cravings, expand our culinary horizons and help us eat things that we might normally dislike. Spices have health-enhancing properties and, in medicine, have been…

PTC Therapeutics halts Utreloxastat development after ALS trial disappoints. Analysts highlight promising pipeline, including Huntington's and PKU programs.